What are the different uses for low dose naltrexone?
Low -floor naltrexone (LDN) is an experimental medical therapy that is examined for the treatment of inflammatory and immune mediated diseases. Proponents of this treatment believe that it increases immune function and may be beneficial for patients with autoimmune diseases. Patients interested in low dose of naltrexone may be able to register with clinical trials for drug access while providing valuable information to doctors and researchers. The drug blocks opioid receptors and is accepted in the treatment of patients with conditions such as the addition of heroin who need help in drug shutdown. In experimental research, the drug shows some applications for diseases caused by autoimmune reactions or a non -functional immune system. Research of the drug is the topic of interest in several medical areas and the latest research data can be found in medical journals, which are dubbing experiments and findings in fields such as treatment of pain and treatment of infectious disease. Doctors usually treatment do notThey are eating, if the patient uses other, clinically proven, medicines. This ensures that patients receive treatment adequate to their needs, if the low dose of naltrexone is not enough to solve the problem. A 2009 study at the University of Stanford suggested that low -dating naltrexone should have pain therapy in patients with fibromyalgia.
In patients with a compromised immune system such as AIDS and cancer patients, low dose nalter can help strengthen the immune system. As part of systemic therapy for the treatment of the disease, it could prolong the quality of life and also imdoca the chances of the patient's survival. These uses are experimental; Opioid drugs are known to have a suppressing effect on the immune system, but scientists do not necessarily believe that low naltrexone may have the opposite effect.
As with other drugs in experimental examination, it can be difficult to access naltExon with a low dose. The doctor may be reluctant to prescribe a medicine without demonstrating evidence that the patient's condition will improve. Insurance companies usually do not cover drugs because they do not approve of experimental drugs. Patients interested in this medicine should discuss this with their doctors and explore the available options; The doctor may not be conveniently prescribed, but could offer recommendations or assistance with connection to clinical evaluation.